Note 19: Warrants

The Company has warrants outstanding to purchase up to 45,511,965 shares of the Company’s common stock as of March 31, 2022 and December 31, 2021.

As of March 31, 2022, 892,857 liability classified derivative warrants to purchase shares of the Company’s common stock remain outstanding and were re-valued at $0.8 million, resulting in a decrease in liability, as compared to December 31, 2021. The change in value is recorded within Net Other Income (Expense) on the condensed consolidated statement of operations. The valuation inputs as of March 31, 2022 included an expected volatility of 124% and an annual interest rate of 2.44%.

The Company did not have any warrant activity during the three months ended March 31, 2022.